CelluPlex LLC v. Uniden America: Bluetooth Patent Dismissed With Prejudice
CelluPlex LLC asserted US7177664B2 — a patent covering Bluetooth interfaces bridging cellular and wired telephone networks — against consumer electronics maker Uniden America in the Northern District of Texas. The parties reached a stipulated dismissal with prejudice in just 152 days, with each side bearing its own legal costs.
A swift stipulated exit: Bluetooth patent claim ends at 152 days
On 3 September 2024, CelluPlex LLC filed suit against Uniden America Corporation in the Northern District of Texas (Case No. 3:24-cv-02247) before Judge Ada Brown, asserting infringement of US7177664B2. The patent covers Bluetooth interface technology enabling communication bridges between cellular and wired telephone networks — a technology directly relevant to Uniden’s consumer communications product portfolio.
The case closed on 2 February 2025 via a Rule 41(a)(1)(A)(ii) stipulated dismissal. Critically, the stipulation is asymmetric: CelluPlex’s infringement claims against Uniden were dismissed with prejudice, permanently extinguishing those claims, while Uniden’s counterclaims against CelluPlex were dismissed without prejudice, preserving Uniden’s ability to refile those claims in a future proceeding. Each party bears its own legal costs.
The 152-day resolution is notably rapid for a patent infringement action and is consistent with an early negotiated resolution — whether settlement, licensing agreement, or strategic withdrawal — reached before significant litigation milestones such as claim construction. The public record does not disclose the commercial terms, if any, that accompanied the stipulation, and the asymmetric prejudice terms suggest the parties negotiated specific protections into the exit structure.
Filing to Dismissed with Prejudice in 152 days
152 days — resolved well under the typical 2–3 year district court patent trial timeline
Dismissed with prejudice: what the stipulated exit means for both parties
Rule 41(a)(1)(A)(ii): a negotiated, stipulated exit
A Rule 41(a)(1)(A)(ii) dismissal requires the written consent of all parties, distinguishing it from a unilateral plaintiff withdrawal. Both CelluPlex and Uniden signed the stipulation, signalling a negotiated resolution rather than a default or forced outcome. The court need not approve the dismissal — it takes effect upon filing, making it one of the cleanest and most final ways to end litigation.
Bilateral stipulationWith prejudice: CelluPlex’s claims are permanently closed
Dismissal with prejudice operates as a final adjudication on the merits, preventing CelluPlex from reasserting these specific infringement claims against Uniden under US7177664B2 in any future action. This is a significant concession by the plaintiff. It suggests either a licensing arrangement was reached, the parties resolved the commercial dispute, or CelluPlex concluded the litigation risk outweighed the expected recovery.
Claims permanently barredUniden’s counterclaims preserved without prejudice
Uniden secured dismissal of its own counterclaims without prejudice, meaning those claims — which could include invalidity challenges to US7177664B2 — remain available for future assertion. This asymmetric structure is notable: it suggests Uniden retained optionality, potentially to challenge the patent’s validity in a future IPR or declaratory judgment action should CelluPlex assert the patent against other defendants or circumstances change.
Counterclaims preservedBluetooth bridging patents: enforcement risk remains for the sector
US7177664B2 survives this litigation without a validity determination. Other manufacturers of Bluetooth-enabled communications devices — particularly those whose products bridge cellular and wired telephone networks — face ongoing exposure to CelluPlex’s patent. The swift, with-prejudice resolution against Uniden does not create collateral estoppel for third parties, and CelluPlex remains free to assert the patent in new actions.
Patent validity undecidedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | CelluPlex LLC | Company | Patent licensing entity — holder of US7177664B2 covering Bluetooth cellular-wired interfacesSearch in Eureka ↗ |
| Defendant | Uniden America, Corp. | Company | Consumer communications electronics manufacturer and marketer in the United StatesSearch in Eureka ↗ |
| Plaintiff counsel | Isaac Philip Rabicoff | Attorney | Counsel for CelluPlex LLCSearch in Eureka ↗ |
| Plaintiff counsel | Michael Scott Fuller | Attorney | Counsel for CelluPlex LLCSearch in Eureka ↗ |
| Plaintiff law firm | Garteiser Honea PC | Law Firm | Representing CelluPlex LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rabicoff Law LLC | Law Firm | Representing CelluPlex LLCSearch in Eureka ↗ |
| Defendant counsel | Lance Eric Wyatt , Jr. | Attorney | Counsel for Uniden America, Corp.Search in Eureka ↗ |
| Defendant counsel | Neil J McNabnay | Attorney | Counsel for Uniden America, Corp.Search in Eureka ↗ |
| Defendant counsel | Riley James Green | Attorney | Counsel for Uniden America, Corp.Search in Eureka ↗ |
| Defendant law firm | Fish & Richardson LLP | Law Firm | Representing Uniden America, Corp.Search in Eureka ↗ |
| Presiding judge | Judge Ada Brown | Judge | Texas Northern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulation’s asymmetric prejudice structure is its most analytically significant feature. CelluPlex’s claims are extinguished with prejudice — a final-adjudication-equivalent bar — while Uniden’s counterclaims survive without prejudice. Courts routinely approve such split-prejudice structures under Rule 41(a)(1)(A)(ii). The ‘each party bears own costs’ clause forecloses any fee-shifting argument under 35 U.S.C. § 285, suggesting neither party characterised the other’s position as objectively unreasonable.
US7177664B2 — Bluetooth interface between cellular and wired telephone networks
US7177664B2 (application number US10/705428) covers technology enabling a Bluetooth interface to bridge cellular telephone networks with wired telephone infrastructure. Filed in the early 2000s, this patent sits at the intersection of wireless communications and PSTN integration — a technically significant domain as Bluetooth was being embedded into consumer communications devices. The patent’s claims likely address the method and apparatus by which a mobile device’s cellular connection is made accessible to a wired network endpoint via a Bluetooth link.
The strategic value of US7177664B2 lies in its applicability to a broad class of consumer electronics — cordless phone systems, home communications hubs, and any device category that routes cellular calls through wired handsets. Uniden’s product portfolio, which includes cordless and cellular-Bluetooth handset systems, falls squarely within this technology space. The patent’s survival without a validity ruling means it remains a live enforcement asset and a risk factor for competitors in the Bluetooth home telephony segment.
Should your product team run an FTO check against US7177664B2?
Any company developing or commercialising products that use Bluetooth to bridge cellular network connections to wired telephone endpoints should treat US7177664B2 as a priority FTO target. This includes manufacturers of cordless phone systems with cellular pairing, home communication hubs, VoIP-cellular bridge devices, and enterprise telephony solutions incorporating Bluetooth cellular tethering. The patent has not been invalidated and CelluPlex retains full enforcement rights.
PatSnap Eureka’s FTO Search Agent can map your product’s technical features against the claim language of US7177664B2, identify prior art that may support an invalidity challenge, and surface related patents in CelluPlex’s portfolio that may present additional risk. Running a structured FTO analysis now — before a demand letter arrives — is materially cheaper and strategically stronger than responding reactively under litigation timelines.
Run a freedom-to-operate analysis on US7177664B2 to assess your product’s exposure
Run FTO in Eureka →Similar Bluetooth and cellular interface patent cases in N.D. Texas
Cases involving Bluetooth communications and cellular-to-wired interface patents litigated in the Northern District of Texas, including related NPE enforcement actions.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Bluetooth interface between cellular and wired telephone networks-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedCelluPlex LLC’s broader IP enforcement history
CelluPlex LLC’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the Bluetooth communications IP landscape
A rapid exit with asymmetric prejudice terms and no cost-shifting contains several signals for IP professionals monitoring cellular-Bluetooth interface patents.
With-prejudice exits signal negotiated value extraction, not defeat
When a patent plaintiff agrees to a with-prejudice dismissal this early — before claim construction — it typically signals a licensing arrangement or commercial resolution was reached. The absence of fee-shifting further supports a consensual outcome rather than a forced capitulation. Companies receiving demand letters from CelluPlex should treat early resolution as a live strategic option.
US7177664B2 remains enforceable and untested on validity
No court has ruled on the validity or scope of US7177664B2 in this case. For product companies in the Bluetooth communications space, this patent continues to represent a live FTO concern. Any company whose products interface cellular networks with wired telephone infrastructure via Bluetooth should conduct claim mapping against this patent before commercialising new products.
Uniden’s preserved counterclaims create a latent IPR threat
Uniden’s without-prejudice counterclaims likely include invalidity arguments that remain actionable. If CelluPlex files new suits asserting US7177664B2, Uniden — or a defendant coalition — could mobilise those preserved challenges, including petitioning for IPR at the USPTO. Monitoring future CelluPlex filing activity is a cost-effective early warning strategy for potential defendants.
N.D. Texas velocity: 152-day resolution as a litigation planning benchmark
The Northern District of Texas under Judge Ada Brown is an active patent venue. This case’s 152-day resolution suggests early-stage settlement pressure is real. Companies anticipating suit in this district should prepare litigation hold procedures and invalidity analyses pre-suit, not post-complaint, to maintain negotiating leverage in the critical first 90 days.
CelluPlex v Uniden — key questions answered
The with-prejudice dismissal of CelluPlex’s claims means those specific infringement allegations under US7177664B2 against Uniden America are permanently extinguished. CelluPlex cannot refile the same claims against Uniden. The dismissal was stipulated under Rule 41(a)(1)(A)(ii), meaning both parties consented, and no court adjudication on the merits occurred.
The stipulation preserved Uniden’s counterclaims by dismissing them without prejudice, meaning Uniden retains the right to assert those claims — potentially including invalidity challenges to US7177664B2 — in future proceedings. This asymmetric structure suggests Uniden negotiated the preservation of its legal optionality as a condition of the settlement or resolution.
CelluPlex asserted US7177664B2 (application no. US10/705428), a patent covering a Bluetooth interface between cellular and wired telephone networks. The patent is relevant to consumer electronics products — such as Uniden’s cordless phone systems — that pair cellular devices with wired telephone infrastructure via Bluetooth.
No. The stipulation expressly provides that each party bears its own costs, expenses, and attorneys’ fees. This mutual cost-bearing arrangement forecloses any claim for fees under 35 U.S.C. § 285 and is consistent with a consensual resolution where neither party sought to characterise the other’s litigation conduct as exceptional.
Yes. US7177664B2 was not invalidated or ruled unenforceable in this proceeding. No claim construction or merits ruling was issued. CelluPlex retains full enforcement rights against other parties, and the patent represents a continuing FTO concern for manufacturers of Bluetooth cellular-to-wired interface products. Companies in this technology space should conduct independent claim mapping and prior art analysis.
Monitor Bluetooth interface patent risk before a demand letter arrives
US7177664B2 remains active and enforceable. Use PatSnap Eureka to run FTO analysis against your Bluetooth communications product line and monitor CelluPlex LLC for new enforcement activity in real time.
PatSnap Eureka searches patents and litigation data to answer instantly.